Neglected diseases see few new drugs despite upped investment

被引:0
|
作者
Cassandra Willyard
机构
来源
Nature Medicine | 2013年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [31] Neglected Diseases - New Compounds and Treatments
    Scotti, Luciana
    Scotti, Marcus T.
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (05) : 659 - 661
  • [32] Spurring New Research For Neglected Diseases
    Anderson, Gerard F.
    HEALTH AFFAIRS, 2009, 28 (06) : 1750 - 1759
  • [33] Neglected Diseases - New Compounds and Treatments
    Scotti, Luciana
    Scotti, Marcus T.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (24) : 4501 - 4503
  • [34] Pathophysiology of heparan sulphate: many diseases, few drugs
    Lindahl, U.
    Kjellen, L.
    JOURNAL OF INTERNAL MEDICINE, 2013, 273 (06) : 555 - 571
  • [35] Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases
    Barder, Owen
    Kremer, Michael
    Williams, Heidi
    ECONOMISTS VOICE, 2006, 3 (03):
  • [36] Drugs for neglected diseases:: a failure of the market and a public health failure?
    Trouiller, P
    Torreele, E
    Olliaro, P
    White, N
    Foster, S
    Wirth, D
    Pécoul, B
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (11) : 945 - 951
  • [37] Donated drugs boost protection against neglected tropical diseases
    Gulland, Anne
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [38] Drugs and vaccines in the 21st century for neglected diseases
    Ferreira, Leonardo L. G.
    Andricopulo, Adriano D.
    LANCET INFECTIOUS DISEASES, 2019, 19 (02): : 125 - 127
  • [40] Expert Delphi survey on research and development into drugs for neglected diseases
    Angela Fehr
    Petra Thürmann
    Oliver Razum
    BMC Health Services Research, 11